Year |
Citation |
Score |
2020 |
Huang J, Sachdeva M, Xu E, Robinson TJ, Luo L, Ma Y, Williams N, Lopez O, Cervia LD, Yuan F, Qin X, Zhang D, Owzar K, Gokgoz N, Seto A, et al. The long non-coding RNA NEAT1 promotes sarcoma metastasis by regulating RNA splicing pathways. Molecular Cancer Research : McR. PMID 32561656 DOI: 10.1158/1541-7786.Mcr-19-1170 |
0.325 |
|
2020 |
Ahmed KA, Kim Y, Armaghani AJ, Arrington JA, Caudell JJ, Costa RL, Czerniecki BJ, Etame AB, Forsyth PA, Khong HT, Kim S, Loftus L, Robinson TJ, Rosa M, Sahebjam S, et al. Abstract OT3-10-01: Phase Ib study of stereotactic radiation and nivolumab in the management of metastatic breast cancer with brain metastases Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot3-10-01 |
0.331 |
|
2019 |
Zaman S, Hajiran A, Coba GA, Robinson T, Madanayake TW, Segarra DT, Chobrutskiy BI, Boyle TA, Zhou JM, Kim Y, Mulé JJ, Teer JK, Manley BJ. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy. European Urology Focus. PMID 31901438 DOI: 10.1016/J.Euf.2019.12.001 |
0.337 |
|
2019 |
Figura NB, Potluri TK, Mohammadi H, Oliver DE, Arrington JA, Robinson TJ, Etame AB, Tran ND, Liu JK, Soliman H, Forsyth PA, Sahebjam S, Yu HM, Han HS, Ahmed KA. CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases. Journal of Neuro-Oncology. PMID 31399935 DOI: 10.1007/s11060-019-03260-6 |
0.309 |
|
2019 |
Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, et al. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy. Breast Cancer Research and Treatment. PMID 30859348 DOI: 10.1016/S0360-3016(19)30416-X |
0.302 |
|
2019 |
Robinson TJ, Freedman JA, Al Abo M, Deveaux AE, LaCroix B, Patierno BM, George DJ, Patierno SR. Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30755441 DOI: 10.1158/1078-0432.Ccr-18-2445 |
0.347 |
|
2019 |
Huang J, Xu E, Sachdeva M, Robinson T, Qin X, Zhang D, Owzar K, Gokgoz N, Seto A, Andrulis I, Wunder J, Okada T, Singer S, Lazar A, Rubin B, et al. Abstract LB-306: Long non-coding RNA NEAT1 promotes lung metastasis of soft tissue sarcoma by regulating RNA splicing pathways Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-306 |
0.304 |
|
2018 |
Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Research. PMID 29351901 DOI: 10.1158/0008-5472.Can-17-1667 |
0.314 |
|
2017 |
Freedman JA, Robinson T, LaCroix B, Patierno B, George D, Sullenger B, Patierno S. Abstract 1232: Development of novel therapeutic splice-switching oligonucleotides targeting oncogenic RNA isoforms driving race-related aggressive prostate cancer Cancer Research. 77: 1232-1232. DOI: 10.1158/1538-7445.Am2017-1232 |
0.302 |
|
2016 |
Goffredo P, Robinson TJ, Youngwirth LM, Roman SA, Sosa JA. Intensity-modulated radiation therapy use for the localized treatment of thyroid cancer: Nationwide practice patterns and outcomes. Endocrine. PMID 27025947 DOI: 10.1007/S12020-016-0937-2 |
0.309 |
|
2016 |
Freedman JA, Robinson TJ, LaCroix B, Patierno BM, George DJ, Sullenger BA, Patierno SR. Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B18 |
0.311 |
|
2016 |
Evans MK, Geradts J, Edwards C, Price A, Arora AJ, Aldrich AJ, Ramirez A, Robinson TJ, Vermeulen PB, Laere Sv, Devi GR. Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-015 |
0.322 |
|
2013 |
Homa NJ, Salinas R, Forte E, Robinson TJ, Garcia-Blanco MA, Luftig MA. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency. Journal of Virology. 87: 12291-301. PMID 24027308 DOI: 10.1128/Jvi.02464-13 |
0.559 |
|
2012 |
Robinson TJ, Forte E, Salinas RE, Puri S, Marengo M, Garcia-Blanco MA, Luftig MA. SplicerEX: a tool for the automated detection and classification of mRNA changes from conventional and splice-sensitive microarray expression data. Rna (New York, N.Y.). 18: 1435-45. PMID 22736799 DOI: 10.1261/Rna.033621.112 |
0.566 |
|
2012 |
Homa N, Salinas R, Forte E, Robinson T, Garcia-Blanco M, Luftig M. EBV-regulated global changes in mRNA isoform usage Infectious Agents and Cancer. 7: O3. DOI: 10.1186/1750-9378-7-S1-O3 |
0.575 |
|
2011 |
Miller HB, Robinson TJ, Gordân R, Hartemink AJ, Garcia-Blanco MA. Identification of Tat-SF1 cellular targets by exon array analysis reveals dual roles in transcription and splicing. Rna (New York, N.Y.). 17: 665-74. PMID 21282347 DOI: 10.1261/Rna.2462011 |
0.639 |
|
2010 |
Robinson TJ, Dinan MA, Dewhirst M, Garcia-Blanco MA, Pearson JL. SplicerAV: a tool for mining microarray expression data for changes in RNA processing. Bmc Bioinformatics. 11: 108. PMID 20184770 DOI: 10.1186/1471-2105-11-108 |
0.584 |
|
2009 |
Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, Rodgers MA, Ramirez JL, Dimopoulos G, Yang PL, Pearson JL, Garcia-Blanco MA. Discovery of insect and human dengue virus host factors. Nature. 458: 1047-50. PMID 19396146 DOI: 10.1038/Nature07967 |
0.653 |
|
2008 |
Pearson JL, Robinson TJ, Muñoz MJ, Kornblihtt AR, Garcia-Blanco MA. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. The Journal of Biological Chemistry. 283: 7949-61. PMID 18187414 DOI: 10.1074/Jbc.M709402200 |
0.57 |
|
Show low-probability matches. |